TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7035545

Group type: EXPERIMENTAL
Intervention: Sequential Spironolactone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination (spironolactone and furosemide)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 90
Study: 31888571

Group type: EXPERIMENTAL
Intervention: Audit data
Number of subjects: 18999

Group type: EXPERIMENTAL
Intervention: Post-audit data
Number of subjects: 18999

Group type: COMPARATOR
Intervention: Pre-audit data
Number of subjects: 18999
Study: 29727056

Group type: EXPERIMENTAL
Intervention: Ketamine + Midazolam (group A)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Propofol (group B)
Number of subjects: 152
Study: 26547918

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 1469

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1469
Study: 25453457

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg plus clopidogrel 75 mg
Number of subjects: 2916

Group type: COMPARATOR
Intervention: Aspirin 325 mg plus placebo
Number of subjects: 2916

Group type: EXPERIMENTAL
Intervention: Blood pressure target <130 mm Hg
Number of subjects: 2916

Group type: COMPARATOR
Intervention: Blood pressure target 130-149 mm Hg
Number of subjects: 2916
Study: 22307842

Group type: EXPERIMENTAL
Intervention: Baseline NT-proBNP levels
Number of subjects: 772
Study: 21336429

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic Acid‐enriched oral nutritional supplement (2 packs per day for 12 weeks) plus dietary counseling
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (only dietary counseling)
Number of subjects: 13
Study: 18349032

Group type: EXPERIMENTAL
Intervention: Exercise and dietary advice (ED)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Exercise-only program (EX)
Number of subjects: 73
Study: 15920225

Group type: EXPERIMENTAL
Intervention: HES 264/0.45 (up to 45 mL/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 5% albumin (up to 45 mL/kg)
Number of subjects: 50
Study: 12045866

Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rossetti fundoplication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 0
Study: 9669185

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 100 mg a day
Number of subjects: 436

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 436
Study: 7634612

Group type: EXPERIMENTAL
Intervention: Pulsed lavage irrigation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Syringe irrigation (Control)
Number of subjects: 12
Study: 2374564

Group type: EXPERIMENTAL
Intervention: Active injections of suspected allergens (60 total injections)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control injections (180 total injections)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Neutralizing doses given by physicians (both suspected allergen and saline)
Number of subjects: 18
Study: 16635

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Amylobarbitone sodium 100 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dichloralphenazone 1300 mg
Number of subjects: 7
Study: 31186035

Group type: EXPERIMENTAL
Intervention: AT supplementation to maintain a functional AT level between 80 and 120%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no AT supplementation)
Number of subjects: 0
Study: 28239939

Group type: EXPERIMENTAL
Intervention: Combination of sitagliptin 100 mg plus fasiglifam 25 mg
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Combination of sitagliptin 100 mg plus fasiglifam 50 mg
Number of subjects: 368

Group type: COMPARATOR
Intervention: Sitagliptin 100 mg
Number of subjects: 368

Group type: COMPARATOR
Intervention: Fasiglifam 25 mg monotherapy
Number of subjects: 368

Group type: COMPARATOR
Intervention: Fasiglifam 50 mg monotherapy
Number of subjects: 368
Study: 25806587

Group type: EXPERIMENTAL
Intervention: Partial Vascular Occlusion (PVO) during rest
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Partial Vascular Occlusion (PVO) during low-intensity resistance exercise (LIRE: 30% 1RM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Moderate-intensity resistance exercise (MIRE: 70% 1RM) without PVO
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Partial Vascular Occlusion (PVO) during moderate-intensity resistance exercise (MIRE)
Number of subjects: 12
Study: 22298417

Group type: EXPERIMENTAL
Intervention: Online CBT
Number of subjects: 105

Group type: COMPARATOR
Intervention: Bibliotherapy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 105
Study: 21083640

Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 3189

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 3189
Study: 19543068

Group type: EXPERIMENTAL
Intervention: Cyclosporine withdrawal (WDL)
Number of subjects: 489

Group type: COMPARATOR
Intervention: Azathioprine and prednisolone (AP)
Number of subjects: 489

Group type: COMPARATOR
Intervention: Long-term cyclosporine alone (Cy)
Number of subjects: 489
Study: 17276718

Group type: EXPERIMENTAL
Intervention: Insulin glargine administered at dinner (n=589)
Number of subjects: 1178

Group type: COMPARATOR
Intervention: Insulin glargine administered at bedtime (n=589)
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Insulin glargine at dinner (FAA subgroup)
Number of subjects: 1178

Group type: COMPARATOR
Intervention: Insulin glargine at bedtime (FAA subgroup)
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Insulin glargine at dinner (RHI subgroup)
Number of subjects: 1178

Group type: COMPARATOR
Intervention: Insulin glargine at bedtime (RHI subgroup)
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 1178
Study: 14996038

Group type: EXPERIMENTAL
Intervention: Maintenance of Wakefulness Test (MWT)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: MWT/ESS discrepancy score (MED)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 151
Study: 11317534

Group type: EXPERIMENTAL
Intervention: Breast conserving treatment (quandrantectomy + radiation)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Modified radical mastectomy
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Localization of tumors (lateral, medial, central)
Number of subjects: 190
Study: 9681665

Group type: EXPERIMENTAL
Intervention: Topical aspirin/diethyl ether (ADE) mixture (750 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Oral aspirin (500 mg)
Number of subjects: 19
Study: 7927958

Group type: EXPERIMENTAL
Intervention: Policosanol 5 mg once-a-day for 8 weeks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Policosanol 5 mg twice-a-day for 8 weeks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Policosanol 10 mg twice-a-day for 8 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 2502890

Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG) therapy, 5 doses every other day, 60-min intravenous infusion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG) therapy
Number of subjects: 6
Study: 1097985

Group type: EXPERIMENTAL
Intervention: Nystatin
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Amphotericin B
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 30948446

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC) exercise
Number of subjects: 0
Study: 31182623

Group type: EXPERIMENTAL
Intervention: Jumpstart Mirror Trainer
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Mirroprep
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control device
Number of subjects: 47
Study: 27807755

Group type: EXPERIMENTAL
Intervention: Social skills group intervention consisting of 32, 2-hour sessions
Number of subjects: 15

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 15
Study: 26277231

Group type: EXPERIMENTAL
Intervention: GlideScope
Number of subjects: 151

Group type: COMPARATOR
Intervention: Macintosh/Miller blades
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Provider type (attendings)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Provider type (certified registered nurse anesthetists)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Provider type (third‐year clinical anesthesia residents)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Sex (men)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Sex (women)
Number of subjects: 151
Study: 23544678

Group type: EXPERIMENTAL
Intervention: Contingency management (CM)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 393
Study: 21300618

Group type: COMPARATOR
Intervention: HPV infections (types 16, 18, 31, 33, 35, 45, 52, 58, 59)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HPV infections (types 16, 18, 31)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HPV infections (type 59)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HPV infections (type 33)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HPV infections (types 16, 33)
Number of subjects: 0
Study: 19590481

Group type: EXPERIMENTAL
Intervention: Active electrical stimulation of acupuncture points on the wrist, 30 minutes, 2 times/week for 4 weeks.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham electrical stimulation of acupuncture points on the wrist, 30 minutes, 2 times/week for 4 weeks.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Active electrical stimulation of acupuncture points on the wrist
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham electrical stimulation of acupuncture points on the wrist
Number of subjects: 60
Study: 16982499

Group type: EXPERIMENTAL
Intervention: Training Group (TG) - 6-month extracurricular training programme (two 50-min sessions per week) involving moderate-intensity impact exercises
Number of subjects: 370

Group type: COMPARATOR
Intervention: Control Group (CG) - No training programme
Number of subjects: 370
Study: 12221048

Group type: EXPERIMENTAL
Intervention: Full-dose almonds (73±3 g/d)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Half-dose almonds
Number of subjects: 27

Group type: COMPARATOR
Intervention: Low-saturated fat whole-wheat muffins
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control diet (whole-wheat muffins)
Number of subjects: 27
Study: 10878510

Group type: COMPARATOR
Intervention: Phenoxymethylpenicillin (40‐60 mg/kg/day) for 10 days (n = 28)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Amoxicillin‐clavulanic acid (20‐40 mg/kg/day) for 10 days (n = 23)
Number of subjects: 51
Study: 7793184

Group type: EXPERIMENTAL
Intervention: Midazolam (0.13 mg.kg‐1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thiopental (4 mg.kg‐1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Midazolam (0.13 mg.kg‐1) combined with Flumazenil (6 micrograms.kg‐1)
Number of subjects: 60
Study: 1954178

Group type: EXPERIMENTAL
Intervention: Ovarian irradiation shortly after mastectomy (experimental group)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Ovarian irradiation planned for the time of first recurrence (control group)
Number of subjects: 346
Study: 7004999

Group type: EXPERIMENTAL
Intervention: Motilin infusion of 0.2 pmol/kg/min
Number of subjects: 7

Group type: COMPARATOR
Intervention: Intravenous saline (control)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Motilin infusion
Number of subjects: 7
Study: 6143184

Group type: EXPERIMENTAL
Intervention: Relaxation therapy alone (group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Relaxation plus biofeedback (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 29790430

Group type: EXPERIMENTAL
Intervention: 1 set resistance training (G1S)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 3 sets resistance training (G3S)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 62
Study: 25917895

Group type: EXPERIMENTAL
Intervention: Probiotic treatment with Saccharomyces boulardii (n = 15)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional treatment (n = 18)
Number of subjects: 33
Study: 24417471

Group type: EXPERIMENTAL
Intervention: At-risk drinkers
Number of subjects: 2779

Group type: COMPARATOR
Intervention: Not-at-risk drinkers
Number of subjects: 2779
Study: 21457354

Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 20736449

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily for 14 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 18515817

Group type: EXPERIMENTAL
Intervention: Group 1 (one suction device)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Group 2 (two suction devices)
Number of subjects: 2
Study: 16030100

Group type: EXPERIMENTAL
Intervention: Twice-weekly weight training (0 to 12 months)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Delayed treatment group (no exercise for 6 months, then training for 6 months)
Number of subjects: 85
Study: 12441750

Group type: EXPERIMENTAL
Intervention: Extracorporeal circulation
Number of subjects: 23

Group type: COMPARATOR
Intervention: No extracorporeal circulation
Number of subjects: 23
Study: 10521838

Group type: EXPERIMENTAL
Intervention: Non-mosaic findings of trisomies 13, 18, and 21
Number of subjects: 20527

Group type: EXPERIMENTAL
Intervention: Mosaic findings of trisomies 13, 18, and 21
Number of subjects: 20527

Group type: EXPERIMENTAL
Intervention: Direct preparations and cultured cells
Number of subjects: 20527

Group type: EXPERIMENTAL
Intervention: Mosaicism for aneuploidies at CVS
Number of subjects: 20527
Study: 7738952

Group type: EXPERIMENTAL
Intervention: Health Assessment Questionnaire (HAQ)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Visual Analog Scale (VAS) for pain
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Total Clinical Score (TCS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Symptoms of TOS
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Laboratory findings
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Predictive factors
Number of subjects: 100
Study: 2074162

Group type: EXPERIMENTAL
Intervention: Naproxen sodium (Nxs) 550 mg twice each day by mouth
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 40
Study: 7018862

Group type: EXPERIMENTAL
Intervention: Cimetidine (dosage not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antacid (specific type not mentioned)
Number of subjects: 0
Study: 30606161

Group type: EXPERIMENTAL
Intervention: Text messages about the availability of oral HIV self-test kits sent three times to the intervention group.
Number of subjects: 2262

Group type: COMPARATOR
Intervention: Enhanced standard of care (SOC) - text messages about HIV testing in general sent three times.
Number of subjects: 2262

Group type: COMPARATOR
Intervention: Standard of care (SOC) - text messages about HIV testing in general sent one time.
Number of subjects: 2262
Study: 28240689

Group type: EXPERIMENTAL
Intervention: Aerosolized budesonide/formoterol
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 26355952

Group type: EXPERIMENTAL
Intervention: Hydrolyzed water‐soluble egg membrane (WSEM), 450 mg daily
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 23542892

Group type: EXPERIMENTAL
Intervention: Specialist-taught physical education (PE) classes (100 min·wk-1)
Number of subjects: 708

Group type: COMPARATOR
Intervention: Control group (general classroom teachers conducting PE)
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Specialist-taught PE
Number of subjects: 708

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 708
Study: 20644971

Group type: EXPERIMENTAL
Intervention: Filtek™ Silorane (low‐shrinkage silorane‐based composite)
Number of subjects: 72

Group type: COMPARATOR
Intervention: CeramX™ (methacrylate‐based composite)
Number of subjects: 72
Study: 20027498

Group type: EXPERIMENTAL
Intervention: Recombinant Hepatitis B vaccine (VrHB‐IB)
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Recombinant Hepatitis B vaccine (VrHB‐IB) with increased antigen concentration to 25 microg
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Control (reference vaccine)
Number of subjects: 1024
Study: 17285408

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 186

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 186
Study: 15712730

Group type: EXPERIMENTAL
Intervention: Post-event method (whole signal acquired through an A/D converter)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real-time method (interface between electrocardiograph and computer for real-time processing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 12782208

Group type: EXPERIMENTAL
Intervention: 400 mg aspartame
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 176 mg aspartic acid + 224 mg phenylalanine
Number of subjects: 6

Group type: COMPARATOR
Intervention: 400 mg corn flour (control)
Number of subjects: 6
Study: 10396563

Group type: EXPERIMENTAL
Intervention: Laser phonosurgery
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional cold phonosurgery
Number of subjects: 44
Study: 7676242

Group type: EXPERIMENTAL
Intervention: Amoxicillin plus clavulanic acid
Number of subjects: 87

Group type: COMPARATOR
Intervention: Amoxicillin plus gentamicin
Number of subjects: 87
Study: 1673971

Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bisoprolol 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bisoprolol 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol 50 mg
Number of subjects: 0
Study: 6128741

Group type: EXPERIMENTAL
Intervention: 15 mg quazepam
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 29581107

Group type: EXPERIMENTAL
Intervention: Transplant center-based patient navigator
Number of subjects: 401
Study: 27046668

Group type: EXPERIMENTAL
Intervention: PTSD Coach app
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 49
Study: 22974139

Group type: EXPERIMENTAL
Intervention: Endovascular embolectomy employing the Merci Retriever or the Penumbra System
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 120
Study: 22030088

Group type: EXPERIMENTAL
Intervention: 200-mg twice daily celecoxib
Number of subjects: 1647

Group type: EXPERIMENTAL
Intervention: 400-mg twice daily celecoxib
Number of subjects: 1647

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1647

Group type: EXPERIMENTAL
Intervention: Withdrawal of 200-mg twice daily celecoxib
Number of subjects: 1647

Group type: EXPERIMENTAL
Intervention: Withdrawal of 400-mg twice daily celecoxib
Number of subjects: 1647

Group type: EXPERIMENTAL
Intervention: Concurrent use of low-dose aspirin
Number of subjects: 1647
Study: 20356526

Group type: EXPERIMENTAL
Intervention: Streamlined Liner of the Pharynx Airway (SLIPA)
Number of subjects: 90
Study: 17884846

Group type: EXPERIMENTAL
Intervention: Transport with tirofiban (10 microg/kg bolus i.v. + i.v. infusion 0.1 microg/kg/min) for primary PCI
Number of subjects: 401

Group type: COMPARATOR
Intervention: On-site thrombolysis
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Transport with tirofiban
Number of subjects: 401
Study: 15699690

Group type: EXPERIMENTAL
Intervention: In vitro gliadin challenge in biopsy cultures of CD children on GFD (group 1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: In vivo gluten challenge in 24 CD children
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (group 2) with no gliadin challenge
Number of subjects: 32
Study: 12744577

Group type: EXPERIMENTAL
Intervention: Real ECT treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Simulated ECT treatment (Control)
Number of subjects: 20
Study: 9831872

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 24
Study: 9160584

Group type: EXPERIMENTAL
Intervention: Pentagastrin 0.2 microgram/kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pentagastrin 0.6 microgram/kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pentagastrin 1.0 microgram/kg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Social interaction task
Number of subjects: 10
Study: 2912330

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (4 micrograms/kg/min given intravenously)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 30796112

Group type: EXPERIMENTAL
Intervention: 80% Basal Rate Reduction (BRR) set 90 min pre-exercise
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 50% Basal Rate Reduction (BRR) set 90 min pre-exercise
Number of subjects: 17

Group type: COMPARATOR
Intervention: Pump Suspension (PS) at exercise onset
Number of subjects: 17
Study: 28434463

Group type: EXPERIMENTAL
Intervention: Prenatal yoga (20-week intervention with two weekly 70-min yoga sessions led by a certified midwife)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Prenatal yoga
Number of subjects: 94

Group type: COMPARATOR
Intervention: Routine prenatal care (control group)
Number of subjects: 94
Study: 25779951

Group type: COMPARATOR
Intervention: Fludarabine plus 2 Gy total body irradiation (TBI)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 8 Gy TLI plus anti-thymocyte globulin (ATG)
Number of subjects: 53
Study: 24113059

Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Topical formalin
Number of subjects: 30
Study: 21982170

Group type: EXPERIMENTAL
Intervention: Halothane anesthesia with oral midazolam premedication (0.5mg/kg 20‐30 minutes before induction)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia with parental presence without premedication
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia with oral midazolam premedication
Number of subjects: 167

Group type: COMPARATOR
Intervention: Halothane anesthesia with parental presence without premedication
Number of subjects: 167